Pfizer Settlement May Have CME Implications

Earlier this month, the largest settlement yet levied against a pharmaceutical company for illegal promotion of a drug was settled against Pfizer and its subsidiary Pharmacia & Upjohn Co. The $2.3 billion fine sanctioned the pharmaceutical company for promoting its painkiller Bextra for off-label uses. Similar charges concerning the drugs Zyvox, Geodon, and Lyrica were also made, along with allegation

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish